A/B TCD Peripheral Blood Stem Cell Transplantation

Phase II, Open-Label, Prospective Study of T Cell Receptor Alpha/Beta Depletion (A/B TCD) Peripheral Blood Stem Cell (PBSC) Transplantation for Children and Adults With Hematological Malignancies

More Information

Trial Status
Accepting patients
Trial Phase
Phase 2
Enrollment
150 patients (estimated)
Sponsors
University of Minnesota - Masonic Cancer Center
Tags
Allogeneic Stem Cell Transplant
Trial Type
Treatment
Last Update
4 weeks ago
SparkCures ID
1870
NCT Identifier
NCT05735717

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.